Interview with Brad Spellberg, MD, author of Evaluation of a Paradigm Shift From Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective Endocarditis: A Narrative Review

Interview with Alfred Sommer, MD, author of Humans, Viruses, and the Eye—An Early Report From the COVID-19 Front Line

Interview with Joshua K Tay, author of Surgical Considerations for Tracheostomy During the COVID-19 Pandemic: Lessons Learned From the Severe Acute Respiratory Syndrome Outbreak, and Babak Givi, MD, author of Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic

Interview with Heidi Jacobe, MD, MSCS, author of Changes in Disease Activity and Damage Over Time in Patients With Morphea

Interview with Reisa A. Sperling, MD, author of Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals

Interview with Naiyer A. Rizvi, MD, author of Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial

Interview with Christopher P. Childers, MD, PhD, and Melinda Maggard Gibbons, MD, authors of Assessment of the Contribution of the Work Relative Value Unit Scale to Differences in Physician Compensation Across Medical and Surgical Specialities

Interview with Charles Dolladille, MD, author of Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer

Interview with Mara A. Schonberg, MD, MPH, author of Effect of a Mammography Screening Decision Aid for Women 75 Years and Older: A Cluster Randomized Clinical Trial, and Quyen Ngo-Metzger, MD, MPH, author of The Life and Death of Mammograms in Patients 75 Years and Older—To Screen or Not to Screen?

Interview with Kristin M Holland, PhD, MPH, author of Trends in the Incidence and Lethality of Suicidal Acts in the United States, 2006 to 2015

Interview with Hsien-Ho Lin, MD, ScD, author of Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset

Interview with Ateev Mehrotra, MD, author of Trends Among Rural and Urban Medicare Beneficiaries in Care Delivery and Outcomes for Acute Stroke and Transient Ischemic Attacks, 2008-2017

Interview with Titus Josef Brinker, MD, author of Effect of a Face-Aging Mobile App–Based Intervention on Skin Cancer Protection Behavior in Secondary Schools in Brazil: A Cluster-Randomized Clinical Trial

The Minister also asked the States to ensure adoption of infection, prevention and control (IPC) practices in all health-care settings to avoid and reduce chances of infections to health-care workers.

Bank of England's statement that Britain could be headed for its biggest economic slump in over 300 years due to the coronavirus lockdown also weighed on the investor sentiment

Expectations of a slow recovery, high fixed costs and debt worries are putting off investors

This was the sixth successive year of net inflows in equity mutual funds

Sugar mills have already dispatched 3.7 million tonnes out of around 4.1 million tonnes of contracts signed for exports in the 2019/20 marketing year ending on September 30

A total of 13 companies, including SBI Cards and Shree Cements, are scheduled to announce their March quarter results today

All that happened in the markets today

The broader structure of Nifty still looks weak though

Primary trend of the stock is positive where stock price is trading above its 200-day SMA

Here's a look at the top stocks that may remain in focus today

Jio Platforms has now raised Rs 60,596.37 crore from leading technology investors in less than three weeks.

The company said, with this, all facilities under warning letter are now determined as Voluntary Action Indicated (VAI)

On Thursday, UK-based Glaxo-SmithKline (GSK) offloaded its stake in HUL via block deals.

The bank's total revenue jumped 33 per cent YoY to Rs 1,522 crore from Rs 1,148 crore reported in Q4FY19, while its net interest income came in at Rs 1,021 crore, up 38 per cent YoY from Rs 739 crore

The company controlled by Mukesh Ambani, is in discussions with banks for a potential sale of its 4.9 per cent stake in Asian Paints through a series of block trades, reports suggest.

Novelis informed that its net income attributable to its common shareholder came in at $63 million for the quarter under review, down 39 per cent year-on-year (YoY

Microsoft is one of the leaders in the cloud computing segment segment, besides Alphabet (Google) and Amazon, making the stock attractive